Diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities - Top-Institutions - MDSpire

Diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities

  • By

  • Jong Eun Lee

  • Hyo-Jae Lee

  • Gyeryeong Park

  • Kum Ju Chae

  • Kwang Nam Jin

  • Eva Castañer

  • Benoit Ghaye

  • Jane P. Ko

  • Helmut Prosch

  • Scott Simpson

  • Anna Rita Larici

  • Jeffrey P. Kanne

  • Thomas Frauenfelder

  • Yeon Joo Jeong

  • Soon Ho Yoon

  • September 23, 2024

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Radiology
    • Pulmonology
    • Interstitial Lung Disease

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Radiology
    • Pulmonology
    • Infectious Diseases

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Radiology
    • Pulmonology
    • Interstitial Lung Disease

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Radiology
    • Pulmonology
    • Interstitial Lung Disease

  • #5

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, Seoul

    Key Differentiators

    • Radiology
    • Pulmonology
    • Interstitial Lung Disease

Original Source(s)

Diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities

  • by Jong Eun Lee, Hyo-Jae Lee, Gyeryeong Park, Kum Ju Chae, Kwang Nam Jin, Eva Castañer, Benoit Ghaye, Jane P. Ko, Helmut Prosch, Scott Simpson, Anna Rita Larici, Jeffrey P. Kanne, Thomas Frauenfelder, Yeon Joo Jeong, Soon Ho Yoon

  • September 23, 2024

Related Content

Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence

Spectral computed tomography characterization of coronary atherosclerotic plaque: principles, imaging biomarkers, and clinical significance

AI Drafts Cut Radiograph Reporting Time

Prospective cohort study found faster documentation, with no statistically significant difference in peer-reviewed report quality